What laboratory tests are recommended for a patient with suspected post-streptococcal glomerulonephritis (PSGN)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Evaluation of Post-Streptococcal Glomerulonephritis

For suspected PSGN, obtain urinalysis with microscopy, serum creatinine, C3 and C4 complement levels, and streptococcal antibody titers (ASO, anti-DNAse B, anti-hyaluronidase) as your core diagnostic panel. 1

Essential Laboratory Tests

Urinalysis and Kidney Function

  • Urinalysis with microscopy showing glomerular hematuria with red blood cell casts and proteinuria (measure albumin-creatinine ratio or protein-creatinine ratio) is the key diagnostic criterion 1
  • Serum creatinine and eGFR to assess for acute kidney injury, which occurs in severe cases 1
  • Microscopic or gross hematuria is the hallmark finding 2, 3

Complement Studies

  • C3 complement level is low in more than 90% of PSGN cases and is the hallmark finding 1, 3
  • C4 complement level typically remains normal, which helps differentiate PSGN from other forms of glomerulonephritis like lupus nephritis 1
  • The decrease in C3 is typically seen earlier than the rise in streptococcal antibody titers 3
  • C3 should normalize within 8-12 weeks; persistently low C3 beyond 12 weeks warrants kidney biopsy to exclude C3 glomerulonephritis 1

Streptococcal Serology

  • Anti-streptolysin O (ASO) titers are valuable for confirming prior streptococcal infection 4, 2
  • Anti-DNAse B antibodies should be measured when ASO is normal but clinical suspicion remains high, as ASO may be negative in up to 10% of cases 1
  • Anti-hyaluronidase antibodies serve as an additional streptococcal marker 1
  • These antibody titers reflect past immunologic events, not acute infection, and are most useful 1-3 weeks after the initial streptococcal infection 4

Additional Laboratory Tests to Exclude Other Diagnoses

When the diagnosis is uncertain or atypical, obtain the following to rule out alternative causes of glomerulonephritis:

  • ANA and anti-dsDNA to exclude lupus nephritis (which causes low C3 AND low C4) 1
  • ANCA (PR3-ANCA and MPO-ANCA) to exclude ANCA-associated vasculitis 1
  • Anti-GBM antibodies to exclude anti-GBM disease 1
  • Cryoglobulins and rheumatoid factor to exclude cryoglobulinemic glomerulonephritis 1

Monitoring Parameters

  • Serum creatinine, urinalysis with microscopy, and urine protein-to-creatinine ratio should be monitored serially 1
  • Blood pressure monitoring is critical as hypertension is a major sequela in the first 7-10 days 3
  • Electrolytes to monitor for hyperkalemia, especially if using ACE inhibitors or ARBs 3

Common Pitfalls to Avoid

  • Do not rely solely on ASO titers: Anti-DNAse B and anti-hyaluronidase antibodies may be positive when ASO is negative, particularly after skin infections 1
  • Do not dismiss the diagnosis if C3 is normal initially: Complement activation may precede clinical onset, and C3 may drop after initial presentation 5
  • Do not delay kidney biopsy if C3 remains low beyond 12 weeks: This suggests an alternative diagnosis such as C3 glomerulonephritis rather than PSGN 1
  • Do not confuse carrier state with active infection: Streptococcal antibody titers confirm prior infection, not current pharyngitis 4

When to Consider Kidney Biopsy

Kidney biopsy is indicated when 4, 1:

  • Diagnosis is uncertain or presentation is atypical
  • C3 remains persistently low beyond 12 weeks
  • Rapidly progressive glomerulonephritis is suspected
  • Alternative diagnoses need to be excluded

References

Guideline

Management of Post-Streptococcal Glomerulonephritis (PSGN)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

When does the C3 (complement 3) level typically return to normal in a patient with post-streptococcal glomerulonephritis (PSGN)?
What is the most appropriate next diagnostic step for a 3-year-old girl presenting with progressive edema, recent sore throat, and laboratory findings indicating impaired renal function, including proteinuria and hematuria, with RBC casts?
What is the most appropriate next diagnostic step for a 3-year-old girl presenting with progressive edema, recent sore throat, and laboratory findings indicating impaired renal function, including proteinuria, hematuria, and the presence of red blood cell (RBC) casts?
When does the C3 level return to normal in a patient diagnosed with acute glomerulonephritis?
What are the complement levels in post-streptococcal (post-strep) glomerulonephritis?
What are the benefits and risks of liposuction for a generally healthy adult patient with a history of medical conditions such as heart disease, diabetes, or previous surgeries?
Why is Blood Urea Nitrogen (BUN) elevated in a patient with upper gastrointestinal bleeding (UGIB)?
What is the management for an elderly female patient with a known history of asthma, presenting with mild fever, productive cough with green sputum, and mild shortness of breath (SOB), and generalized wheeze on exam?
What is the best management approach for a patient presenting with acute hemorrhoids?
What are the considerations for using glycopyrrolate in a patient with overactive bladder symptoms, potentially as an alternative to oxybutynin (Ditropan) or tolterodine (Detrol)?
What tests should be included in a basic metabolic panel for a 56-year-old male patient with a history of intermittent headaches and recent alcohol consumption?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.